| http://www.w3.org/ns/prov#value | - Finding these claims were a direct challenge to the FDA???s control over labeling content and over issuance of such letters to physicians, the FDA argued that these claims could not stand in the face of the Agency???s approval of the existing warnings and the FDA???s power to order notices to the public, and that the FDA had primary jurisdiction over such matters.
|
